Darbepoetin alfa
Strengths: 25 mg, 50 mg, 75 mg, 150 mg, 300 mg, 500 mcg
Dosage Form: Injection
Description:
Darbepoetin alfa is a long-acting erythropoiesis-stimulating agent used to treat anemia associated with chronic kidney disease and chemotherapy by stimulating red blood cell production.
Key Features:
- Longer half-life allowing less frequent dosing
- Improves quality of life by reducing anemia symptoms
- Injectable form
Precautions:
Avoid excessive hemoglobin increase. Monitor iron status and blood pressure during therapy.